Leigh Stevens, MD
Pain Medicine · Hickory, NCNPI 1558358770
Payments from drug & device makers
Across 229 payments — averaging $33.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Nevro Corp.$2K
- Boston Scientific$1K
- Collegium Pharmaceutical, Inc.$340
- AbbVie$311
- Merz Pharmaceuticals, LLC$286
- plus $1K from 28 others
What the payments were for
- Travel & lodging$2,35531%
- Food & beverage$5,17468%
- Education$691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 29 | $2,284 |
| Nevro Corp. | 20 | $1,653 |
| Boston Scientific | 67 | $1,224 |
| Collegium Pharmaceutical, Inc. | 21 | $340 |
| AbbVie(2 entities) | 18 | $311 |
| Merz Pharmaceuticals, LLC | 12 | $286 |
| Saluda Medical Americas, Inc. | 6 | $218 |
| Abbott | 6 | $113 |
| Curonix LLC | 6 | $108 |
| Vivus LLC | 1 | $97 |
| Vertiflex, Inc. | 1 | $97 |
| Stimwave Technologies Incorporated | 2 | $87 |
| Novo Nordisk | 5 | $77 |
| GRT US Holding, Inc. | 5 | $75 |
| Vertos Medical, Inc. | 2 | $60 |
| Painteq LLC | 2 | $59 |
| SPR Therapeutics, Inc | 2 | $57 |
| Globus Medical | 2 | $46 |
| Virtus Pharmaceuticals LLC | 2 | $43 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| Vertex | 2 | $39 |
| Scilex Pharmaceuticals Inc. | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Lilly USA, LLC | 2 | $28 |
| Averitas Pharma Inc. | 1 | $27 |
| Rhythm Pharmaceuticals, Inc. | 1 | $26 |
| Forte Bio-pharma LLC | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $23 |
| GSK | 1 | $17 |
| Inari Medical, Inc. | 1 | $16 |
| Biotronik NRO, Inc. | 1 | $16 |
| Nalu Medical, Inc. | 1 | $14 |
| Eagle Pharmaceuticals, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,598 in reported general payments places this provider in the 65th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 57 | $43,091 |
| OxycontinOxycodone Hcl | 54 | $36,439 |
| NucyntaTapentadol Hcl | 13 | $18,139 |
| Aimovig AutoinjectorErenumab-Aooe | 19 | $16,805 |
| OzempicSemaglutide | 13 | $16,329 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 489 | $16,269 |
| Buprenorphine | 70 | $12,956 |
| Xtampza ErOxycodone Myristate | 23 | $11,725 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 369 | $11,262 |
| Diclofenac Sodium | 37 | $7,417 |
| Oxycodone Hcl | 377 | $7,040 |
| Morphine Sulfate ErMorphine Sulfate | 127 | $5,856 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 19 | $5,268 |
| Fentanyl | 41 | $3,601 |
| Gabapentin | 262 | $3,321 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta, Xtampza Er | $340 | $72,95593 claims |
| Novo NordiskOzempic | $77 | $16,32913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 182 pain medicine providers in North Carolina.
Other pain medicine in Hickory
- Leonardo KapuralWinston Salem$4.1M
- James NorthWinston Salem$3.7M
- Richard RauckWinston Salem$1.7M
- Christopher GilmoreWinston Salem$1.3M
- Binit ShahHuntersville$863K
- Jeffrey PeacockWinston Salem$553K
- Courtney AumanJacksonville$210K
- Javid BakshAsheville$202K
- David ZubLeland$168K
- Jacob WangCharlotte$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.